While SOX9 is known to be transcriptionally repressed by β-catenin in cartilage development (43, 44) and found to contribute to a number of cancer types including CRC (15, 45, 46),, only recently through a comprehensive molecular characterization of CRC has mutations in this transcription factor been implicated in any type of human cancers (32). Here, SOX9 is linked to cancer.